The Heavy Hitters of Transplant ID (IDWeek 2026) - Aug 1, 2026 - Pres time: Oct 22, 2026; 01:45 PM - 03:00 PM; Location: 209 ABC; "Learning Objectives: At the conclusion of this session, participants will be able to:Analyze the epidemiologic exposure risks, timeline after transplantation (early, intermediate, late), and distinct clinical manifestations of major opportunistic pathogens in solid organ (SOT) and hematopoietic stem cell transplant (HSCT) recipients focusing on high-consequence viral (CMV, EBV, BK virus) and invasive fungal pathogens (Aspergillus, Mucorales)Evaluate modern diagnostic modalities for complex transplant-related infections, including quantitative viral PCR monitoring, resistance genotyping (e.g., UL97/UL54 mutations in refactory CMV), and non-invasive fungal biomarkers to guide timely clinical intervention.Develop patient-specific prevention and treatment plans that integrate novel antimicrobial agents (e.g., maribavir, letermovir, isavuconazole), adjust underlying immunosuppressive therapy to balance rejection risk against infection control, and apply preemptive..."
Infectious Disease
|
|
Denise Francisco, MD (she/her/hers); Shipra Goel, MD (she/her/hers)
|